Researchers at Swansea University discovered that a medicine frequently used to treat type 2 diabetes might possibly be used to treat autoimmune illnesses.
A new study proposes a novel strategy to treat type 2 diabetes, putting individuals in command of their own medicine. The Trimaster study is the first to allow persons with type 2 diabetes to choose their own medicine following a series of three different drugs. It came to the conclusion tha
Washington [US], September 18 (ANI): In comparison to other diabetic medications, tirzepatide accomplishes blood sugar control and weight loss goals more quickly, according to new research examining the time needed to attain blood glucose targets.